Status:
COMPLETED
Imaging-Guided Vessel Sizing in the Tibial Arteries
Lead Sponsor:
University Hospitals Cleveland Medical Center
Collaborating Sponsors:
Abbott Medical Devices
Conditions:
Peripheral Artery Disease
Critical Limb Ischemia
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to investigate the utilization of intravascular imaging in treatment of tibial vessels in peripheral artery disease and critical limb ischemia (CLI). The primary goal is to compare opt...
Detailed Description
This is a prospective, nonrandomized trial to investigate the adjunctive use of intravascular imaging in tibial vessel interventions. The evaluation of OCT is primarily to: (a) establish feasibility a...
Eligibility Criteria
Inclusion
- Age \>18
- Patients with presence of Rutherford IV-VI
- Presence of ≥1 tibial artery involvement requiring endovascular treatment
Exclusion
- Patients who do not have tibial disease appropriate for intervention
- Estimated glomerular filtration rate \<30 mL/min not on hemodialysis
Key Trial Info
Start Date :
August 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 9 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04748965
Start Date
August 16 2021
End Date
June 9 2024
Last Update
May 2 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Ahuja Medical Center
Beachwood, Ohio, United States, 44122
2
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States, 44106
3
University Hospitals Parma Medical Center
Parma, Ohio, United States, 44129